Skip to content

Tag: Nmda receptor

Explore our medication guides and pharmacology articles within this category.

Does Amantadine Help ADHD? Exploring the Off-Label Treatment Option

4 min read
Originally developed as an antiviral drug in the 1960s, amantadine is sometimes used off-label by clinicians to help manage the symptoms of ADHD, though it lacks U.S. Food and Drug Administration (FDA) approval for this purpose. This practice is typically reserved for individuals who do not tolerate or respond well to conventional stimulant treatments.

An Emerging Off-Label Option: Is Memantine Used for Migraines?

4 min read
Affecting nearly 1 in 7 people globally, migraine is a leading cause of disability [1.9.5]. While not FDA-approved for this purpose, a growing body of evidence explores the question: **is memantine used for migraines?** This Alzheimer's medication is showing promise as an off-label preventive treatment [1.3.1, 1.3.2].

The Clinical Answer: Is Dextromethorphan an Opioid?

4 min read
In 2020, 3.7% of teens reported using over-the-counter (OTC) cough medicine containing dextromethorphan to get high [1.5.1]. This raises a critical question for many: **Is dextromethorphan an opioid?** The answer is more complex than a simple yes or no.

Unveiling the Mechanisms: What Does Lysine Do for Pain?

5 min read
With chronic pain posing a significant clinical challenge, research is exploring safer alternatives to traditional analgesics. One promising candidate is L-lysine, an essential amino acid the body cannot produce on its own. So, what does lysine do for pain? Emerging evidence suggests it influences pain through multiple neurological and anti-inflammatory pathways.

How Does Amantadine Work on Dopamine? A Pharmacological Review

4 min read
Initially developed as an antiviral for influenza A, amantadine was serendipitously found to have antiparkinsonian effects [1.3.7, 1.3.4]. The central question for its use in movement disorders is: how does amantadine work on dopamine? Its complex pharmacology involves multiple pathways, primarily increasing dopamine levels in the brain [1.3.1, 1.3.2].

How does auvelity work in the brain? A guide to its unique dual-action mechanism

2 min read
Approved by the FDA in 2022, Auvelity represents a significant milestone in antidepressant therapy, offering a novel oral mechanism of action not seen in over 60 years. To understand **how does auvelity work in the brain?**, one must explore the synergistic effects of its two active components, dextromethorphan and bupropion, which target different neurochemical systems for rapid symptom relief.